-
Share
13/06/14
15:57
Share
You mean PI-88 ?
http://www.biocentury.com/companies/medigen_biotechnology_corp
In my opinion Phase III Data that came in in may can´t be that bad giving market reaction at medigen...
2.2B Dollar company now ...
10% royalty sales to progen... PI-88 lead product for medigen... don´t see why we are worth less than 10% of medigen... thats north of 4$ now...
(OK medigen has some vaccines and another product - both early stage - but progens manufacture business should also get a boost and PGP545...)
-